glp-1 and stroke GLP-1s could improve survival after heart attack The Paper of The Month

The FDA has approved GLP-1 and related medications for chronic weight management in adults with obesity or adults with overweight and at least one weight-related condition, when used along with reduced-calorie nutrition and increased physical activity

comparing metformin, liraglutide, and combination therapy (metformin 1000 mg BID + liraglutide 1.2 mg/day), the latter, and not liraglutide 1.2 mg/day alone, was superior to metformin alone in reducing glucose levels at 120 min during OGTT [61]

One peptide in particular, Peptide BPC 157, has shown clinical promise in enhancing muscle recovery, making it a popular choice among athletes and fitness enthusiasts

Reflect inner health

However, it is not FDA-approved for human use and cannot legally be marketed as a drug, supplement, or for human consumption

But it is just that: an assumption, added Dr Pacey, who was not part of the research team